Annuncio pubblicitario
Italia markets closed

  • FTSE MIB

    34.249,77
    +310,02 (+0,91%)
     

  • Dow Jones

    38.287,41
    +201,61 (+0,53%)
     

  • Nasdaq

    15.933,38
    +321,62 (+2,06%)
     

  • Nikkei 225

    37.934,76
    +306,28 (+0,81%)
     

  • Petrolio

    83,90
    +0,33 (+0,39%)
     

  • Bitcoin EUR

    59.804,50
    -723,23 (-1,19%)
     

  • CMC Crypto 200

    1.331,87
    -64,66 (-4,63%)
     

  • Oro

    2.350,30
    +7,80 (+0,33%)
     

  • EUR/USD

    1,0702
    -0,0031 (-0,29%)
     

  • S&P 500

    5.106,29
    +57,87 (+1,15%)
     

  • HANG SENG

    17.651,15
    +366,61 (+2,12%)
     

  • Euro Stoxx 50

    5.006,85
    +67,84 (+1,37%)
     

  • EUR/GBP

    0,8561
    -0,0013 (-0,15%)
     

  • EUR/CHF

    0,9774
    -0,0011 (-0,12%)
     

  • EUR/CAD

    1,4618
    -0,0031 (-0,21%)
     

OPKO Health Announces Participation in Piper Sandler 33rd Annual Virtual Healthcare Conference

Opko Health, Inc.
·1 minuto per la lettura

MIAMI, Nov. 29, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the Piper Sandler 33rd Annual Virtual Healthcare Conference taking place November 30 through December 2, 2021. A pre-recorded company fireside chat is available for registered attendees via the Piper Sandler conference site and at this link.

Management will be available for one-on-one virtual meetings with investors on Wednesday, December 1st, which can be requested through Piper Sandler.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.

Contacts:

LHA Investor Relations
Yvonne Briggs, 310-691-7100
ybriggs@lhai.com
or
Bruce Voss, 310-691-7100
bvoss@lhai.com